Table 4 Analyses of main outcomes during emergence and recovery. Values are numbers (proportion)
Sugammadex 1 mg + 1 mg/kg group n = 40 | Neostigmine group n = 40 | RR (95% CI) | p-value | |
|---|---|---|---|---|
Emergence of severe cough | ||||
Yes | 5 (12.5) | 7 (17.5) | 0.71(0.25–2.06) | p = 0.531 |
No | 35 (87.5) | 33 (82.5) | ||
Emergence agitation | ||||
Yes | 6 (15.0) | 3 (7.5) | 2.00 (0.54–7.45) | p = 0.480 |
No | 34 (85.0) | 37 (92.5) | ||
Cough in PACU | ||||
Yes | 3 (7.5) | 3 (7.5) | 1.00 (0.21–4.66) | p = 1.000 |
No | 37 (92.5) | 37 (92.5) | ||
Sore throat | ||||
Yes | 21 (52.5) | 18 (45.0) | 1.17 (0.74–1.83) | p = 0.502 |
No | 19 (47.5) | 22 (55.0) | ||
Sugammadex 2 mg/kg group n = 40 | Neostigmine group n = 40 | RR (95% CI) | p-value | |
Emergence of severe cough | ||||
Yes | 28 (70.0) | 7 (17.5) | 4.00 (1.98–8.08) | p < 0.001 |
No | 12 (30.0) | 33 (82.5) | ||
Emergence agitation | ||||
Yes | 14 (35.0) | 3 (7.5) | 4.67 (1.45–15.00) | p = 0.003 |
No | 26 (65.0) | 37 (92.5) | ||
Cough in PACU | ||||
Yes | 12 (30.0) | 3 (7.5) | 4.00 (1.22–13.11) | p = 0.010 |
No | 28 (70.0) | 37 (92.5) | ||
Sore throat | ||||
Yes | 30 (75.0) | 18 (45.0) | 1.67 (1.13–2.45) | p = 0.006 |
No | 10 (25.9) | 22 (55.0) | ||
Sugammadex 1 mg + 1 mg/kg group n = 40 | Sugammadex 2 mg/kg group n = 40 | RR (95% CI) | p-value | |
Emergence of severe cough | ||||
Yes | 5 (12.5) | 28 (70.0) | 0.21 (0.10–0.45) | p < 0.001 |
No | 35 (87.5) | 12 (30.0) | ||
Emergence agitation | ||||
Yes | 6 (15.0) | 14 (35.0) | 0.43 (0.18–1.00) | p = 0.039 |
No | 34 (85.0) | 26 (65.0) | ||
Cough in PACU | ||||
Yes | 3 (7.5) | 12 (30.0) | 0.25 (0.08–0.82) | p = 0.010 |
No | 37 (92.5) | 28 (70.0) | ||
Sore throat | ||||
Yes | 21 (52.5) | 30 (75.0) | 0.70 (0.50–0.99) | p = 0.036 |
No | 19 (47.5) | 10 (25.0) | ||